The decreased functional capacity appears to be related to plasmin-mediated proteolysis in some of the patients with very advanced disease (ie, decompensated cirrhosis/acute-on-chronic liver failure and acute liver failure or acute liver injury), whereas no cVWF was detected in patients with stable cirrhosis. The gene discussed is PLG; the disease is acute-on-chronic liver failure.